Welcome to IthaMaps

IthaMaps is a global epidemiology database of heamoglobinopathies, illustrating published data on a dynamic global to regional map. Country-specific information on haemoglobinopathy-related policies, prevalence, incidence and overall disease burden is given, including relative allele frequencies of specific globin mutations in each country and/or region, dynamically linked to corresponding IthaGenes entries.

IthaMaps content was supported by partnership with the HVP Global Globin 2020 Challenge

Search

Search Country: OR Search for:  Show organisations

  General information for Cuba


Cuba
Continent: North America
Capital: Havana
Population: 11423000
Area (in sq km): 110860.0

Haemoglobinopathy-specific healthcare policy information for Cuba

Healthcare policyComment/InfoReference
Prevention programme: Yes (National)Screening pregnant women and couples for carrier status as part of the Sickle Cell Anemia Prevention program implemented in 1982[PMID: 32335567]
SCD newborn screening: No[PMID: 32335567]
Prenatal screening: Yes (National)For the diagnosis of SCD genotypes in the fetus.[PMID: 32335567]
Antenatal screening: Yes (National)Screening of pregnant women as part of the Sickle Cell Anemia Prevention program implemented in 1982.[PMID: 32335567]
Genetic counselling: Yes (National)As part of the Sickle Cell Anemia Prevention Programetus [PMID: 32335567]

  Prevalence and incidence of major haemoglobinopathies in Cuba

HaemoglobinopathyComment/InfoReference
Prevalence of β-thalassaemia carriers: 0.75 % of the population[PMID: 24672827]
Prevalence of sickle cell disease carriers: 3.2 % of the population%AS varies across provinces from 1.7% to 6.3%. Antenatal testing for SCD during 1982-2018 [PMID: 32335567]
Prevalence of Hb E carriers: 0 % of the populationFrom: Modell's Haemoglobinopathologist's Almanac.
Prevalence of Hb C carriers: 0.6 % of the populationScreening of pregnant women during 1982-2018.[PMID: 32335567]
Expected incidence of β-thalassaemia: 2 expected affected births/year[PMID: 24672827]
Expected incidence of sickle cell disease: 39 expected affected births/year[PMID: 24672827]
Incidence of sickle cell disease: 240 affected births/yearMedian value estimated using statistical model and demographic data.[PMID: 23103089]
Known sickle cell disease patients: 4000 patients[PMID: 24672827]

  Global Burden of Disease data for Cuba

  Migration data for Cuba

Mutation frequencies in Cuba

 Overview (most frequent mutations with their observed average values and range)

 β-locus

CD 41/42 (-CTTT): 34.3 % (6.1 % – 62.5 %)CD 39 CAG>TAG [Gln>STOP]: 32.93 % (21.1 % – 47.2 %)
-29 (A>G): 17.4 % (12.5 % – 26.3 %)IVS I-110 G>A: 9.17 % (7.9 % – 11.1 %)

 Detailed mutation frequencies

Entry IDLocusRegionEthnic GroupPopulation TypeSample SizeStudy period (from)Study period (to)ReferenceComments
23576β-locusCountry-wideCubanCarriers and Patients82200010815781Frequencies are shown for beta-globin gene mutations. The study samples consisted of European-Cubans, African-Cubans, and Asian-Cubans.
23577β-locusCountry-wideEuropean-CubanCarriers and Patients36200010815781Frequencies are shown for beta-globin gene mutations.
23578β-locusCountry-wideAfrican-CubanCarriers and Patients38200010815781Frequencies are shown for beta-globin gene mutations.
23579β-locusCountry-wideAsian-CubanCarriers and Patients8200010815781Frequencies are shown for beta-globin gene mutations.

  Organisations in Cuba

Organisations in Cuba are currently not available

 Microattributions

No microattibutions were provided for Cuba. Please contact us, if you are willing to review existing information or provide new data.

To provide new epidemiological information and/or report mistakes, please register/log in first or use the Contact Us form.

Important Note: The relative allele frequencies presented in IthaMaps are not calculated by ITHANET, but they are extracted from the corresponding publications. ITHANET is not responsible for any mistakes in the data. Please use this information with caution! We encourage scientists that have more detailed or updated epidemiological information to contact us.

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaMaps are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.